Dr James H. Sabry

Personal Data

Nationality: Canadian and American
Year of Birth: 1958

Position

Global Head of Pharma Partnering

Studies

• M.D. - Queen’s University, 1983 (Kingston, Canada)
• M.Sc. - California Institute of Technology, Biology, 1989 (Pasadena, USA)
• Ph.D. - University of California, San Francisco, Neuroscience, 1994 (San Francisco, USA)
• Postdoctoral fellow - Stanford University, Biochemistry, 1994-1998 (Stanford, USA)

Professional Career

• 1984-1987
  Harvard Medical School (Boston, USA), Resident in Neurology
• 1987
  Harvard Medical School (Boston, USA), Chief Resident in Neurology
• 1989-1998
  University of California, San Francisco (San Francisco, USA), Adjunct Clinical Appointment in the Department of Neurology
• 1997-2006
  Co-founder, President and CEO of Cytokinetics 
• 2008-2010
  President and CEO of Arete Therapeutics
• 2010-2013
  Global Head and Vice President of Genentech Partnering, USA
• 2013-2018
  Global Head and Senior Vice President of Genentech Partnering, USA
• 2018
  Global Head of Pharma Partnering, Roche Basel, Switzerland

Other Activities / Memberships

• since 1998
  Member of Scientific Advisory Board at Cytokinetics
• 2007-2008
  Executive Chairman of the Board of Directors of Cytokinetics
• 2008-2010
  Chairman of the Board of Directors of Cytokinetics
• 2005-2016
  Member of the Board of Directors of HopeLab 
• 2015-2016
  Member of the Board of Directors of California Life Sciences Association
• 2016-2020
  Member of the Board of Directors of Coalition for the Life Sciences

Board Memberships in listed companies

• since April 2019
  Member of the Board of Directors of Chugai Pharmaceutical Co., Ltd.